MutualFundWire.com: In Demand
MutualFundWire.com
   The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication
Thursday, February 8, 2001

In Demand


Investors clamoring for more ETFs got what they wanted, as Barclays Global International introduced a new iShare, under the ticker symbol IBB, that tracks the Nasdaq Biotechnology Index.

"An exchange traded fund that tracks the biotech sector was one of the most requested from our customers," said Lee Kranefuss, chief executive officer of BGI's Individual Investor Group in a statement.

The companies followed by the index develop new treatments and cures from biomedical research.


Printed from: MFWire.com/story.asp?s=26414

Copyright 2001, InvestmentWires, Inc.
All Rights Reserved
Back to Top